Researchers at the University of Toronto, The Hospital for Sick Children (SickKids), St. Paul's Hospital and the University of British Columbia have identified a new treatment target for a virus that causes severe lung infections and an estimated 10% of common colds. The virus, called human respiratory syncytial virus or RSV, is the most common reason for hospitalization of infants and children under two years of age; currently there is no effective therapy or vaccine for it.
Approximately one-half of all infants are infected with the respiratory syncytial virus (RSV) during the first year of life, and almost all children have been infected at least once by the time they reach their second birthday. Rese... Read Post
Respiratory Syncytial Virus (RSV) is a common virus that causes infections of the lungs and respiratory tract. Although symptoms are usually mild and mimic the common cold in adults and older, healthy children, RSV can be severe in ... Read Post